Linda, L. (2017). The Ninja’s Guide to Prite (10th ed.). Retrieved from http://www.llupsychresidency.com/wp-content/uploads/2017/09/2017-Ninja-PRITE-Study-Guide.pdf
Meyer, Jerrold S., et al. Psychopharmacology: Drugs, the Brain, and Behavior. Oxford University Press, 2019.
Nenadic, I., Maitra, R., Langbein, K., Dietzek, M., Lorenz, C., Smesny, S., … & Gaser, C. (2015). Brain Structure in Schizophrenia vs. Psychotic Bipolar I Disorder: A VBM Study. Retrieved from http://dbm.neuro.uni-jena.de/pdf-files/Nenadic-SR15.pdf
Nieman, D. H. (2015). The Lancet Psychiatry. New Treatments for Psychotic Disorders. 282-283. Retrieved from http://www.thelancet.com/pdfs/journals/lanpsy/PIIS2215-0366(15)00093-0.pdf
Selemon, L D, and N Zecevic. “Schizophrenia: a Tale of Two Critical Periods for Prefrontal Cortical Development.” Translational Psychiatry, vol. 5, no. 8, 2015, doi:10.1038/tp.2015.115.
Twenge J, Cooper A, Joiner T, Duffy M, Binau S. Age, period, and cohort trends in mood disorder indicators and suicide-related outcomes in a nationally representative dataset, 2005-2017 [published online March 14, 2019]. J Abnorm Psychol. doi: 10.1037/abn0000410.
Venigalla, H., Mekala, H. M., Hassan, M., Ahmed, R., Zain, H., Dar, S., & Veliz, S. S. (2017). An Update on Biomarkers in Psychiatric Disorders – Are we aware, Do we use in our clinical practice?. Retrieved from https://www.mhfmjournal.com/open-access/an-update-on-biomarkers-in-psychiatric-disorders–are-we-aware-do-we-use-in-our-clinical-practice.pdf
Zheutlin, Amanda B., et al. “Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia in 106,160 Patients Across Four Health Care Systems.” American Journal of Psychiatry, vol. 176, no. 10, 2019, pp. 846–855., doi:10.1176/appi.ajp.2019.18091085.
